Table 1 Age-specific prevalence of epiretinal membrane.
Age range (years) | Number of participants | CMR N (%) | PMF N (%) | Any ERM N (%) |
---|---|---|---|---|
Men, N (%) | ||||
40–49 | 89 | 0 (0) | 1 (1.1) | 1 (1.1) |
50–59 | 121 | 5 (4.1) | 0 (0) | 5 (4.1) |
60–69 | 327 | 33 (10.1) | 14 (4.3) | 47 (14.4) |
70–79 | 223 | 33 (14.8) | 10 (4.5) | 43 (19.3) |
80+ | 37 | 7 (18.9) | 1 (2.7) | 8 (21.6) |
Total | 797 | 78 (9.8) | 26 (3.3) | 104 (13.1) |
Women, N (%) | ||||
40–49 | 140 | 2 (1.4) | 3 (2.1) | 5 (3.6) |
50–59 | 218 | 6 (2.8) | 7 (3.2) | 13 (6.0) |
60–69 | 482 | 48 (10.0) | 29 (6.0) | 77 (16.0) |
70–79 | 275 | 25 (9.1) | 21 (7.6) | 46 (16.7) |
80+ | 41 | 4 (9.8) | 3 (7.3) | 7 (17.1) |
Total | 1156 | 85 (7.4) | 63 (5.5) | 148 (12.8) |
Total, N (%) | ||||
40–49 | 229 | 2 (0.87) | 4 (1.8) | 6 (2.6) |
50–59 | 339 | 11 (3.2) | 7 (2.1) | 18 (5.3) |
60–69 | 809 | 81 (10.0) | 43 (5.3) | 124 (15.3) |
70–79 | 498 | 58 (11.7) | 31 (6.2) | 89 (17.9) |
80+ | 78 | 11 (14.1) | 4 (5.1) | 15 (19.2) |
Total | 1953 | 163 (8.4) | 89 (4.6) | 252 (12.9) |